Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04609579
Title Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Silicon Therapeutics
Indications

colorectal cancer

ovarian cancer

lymphoma

Advanced Solid Tumor

Therapies

SNX281

Pembrolizumab + SNX281

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.